Change over period: —
NSE · EIDPARRY
E.I.D.PAR
-39.5% from the 52-week high · +7.8% above the low
E.I.D.-Parry (India) Ltd. engages in the manufacture and marketing of sugar. The company is headquartered in Chennai, Tamil Nadu and currently employs 2,230 full-time employees. - Parry (India) Limited is an India-based company, which is primarily engaged in the manufacturing of sugar and nutraceuticals. The firm has a presence in the farm inputs business, including bio-pesticides through its subsidiary, Coromandel International Limited. Its segments include Nutrient and allied business, Crop Protection, Sugar, Co-generation, Distillery, Nutraceuticals and Others. The company offers customized grades of pharmaceutical sugar to a range of pharma applications, such as tablet coatings, liquid orals, dry syrups, intravenous applications and in drug delivery systems. The company is a vendor to various specialty and industries, such as infant-food, beverages, and confectionary, among others. Its nutraceutical products include Organic Spirulina, Organic Chlorella and Organic Phycocyanin, among others. The company also offers hand sanitizer and medical grade hand sanitizer. The firm has approximately nine sugar plants, which are spread across South India.
The short version. E.I.D.PAR reported revenue of ₹11,213 crore for Sep 2026, down 3.5% from a year earlier. Net profit was ₹253 crore (down 40.3% year on year). Return on equity was 6.5% in Mar 2026. Promoter holding was 41.28% in Sep 2026, down 0.41 points over 8 quarters.
1 · The price
How has the stock traded?
E.I.D.PAR trades 39.5% below its 52-week high and 7.8% above its 52-week low.
2 · The business
Is it growing?
Sep 2026 revenue of ₹11,213 cr.
Sep 2026 net profit of ₹253 cr.
1.4 pts lower than a year earlier.
Revenue compounded at 3.3% over the same 3 years.
Reported results · ₹ crore
Revenue and profit
Show the numbers
Quarterly
| Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | 11213 | 9018 | 7882 | 10316 | 11624 | 8724 | 6811 | 8720 |
| Net profit | 253 | 142 | -333 | 232 | 424 | 246 | 287 | 195 |
| Net margin % | 2.3 | 1.6 | -4.2 | 2.3 | 3.7 | 2.8 | 4.2 | 2.2 |
| EPS (₹) | 14.21 | 7.96 | -18.74 | 13.05 | 23.86 | 13.85 | 16.12 | 10.97 |
Annual
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | 38534 | 31609 | 29413 | 35244 | 23528 | 18587 | 17129 | 16565 |
| Net profit | 570 | 878 | 900 | 947 | 907 | 447 | 468 | 153 |
| Net margin % | 1.5 | 2.8 | 3.1 | 2.7 | 3.9 | 2.4 | 2.7 | 0.9 |
| EPS (₹) | 32.02 | 49.41 | 50.68 | 53.37 | 51.12 | 25.26 | 26.43 | 8.67 |
3 · The quality
How well does it turn capital into profit?
Return on equity was 6.5% in Mar 2026; debt to equity is 0.33.
Profitability · 4 years
Returns and margins
| Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | |
|---|---|---|---|---|
| Return on equity % | 6.5 | 11.1 | 12.8 | 15.6 |
| Return on capital % | 15.9 | 20.6 | 20.5 | 28.1 |
| EBITDA margin % | 8.5 | 10.6 | 9.8 | 9.3 |
| Net margin % | 1.5 | 2.8 | 3.0 | 2.7 |
Compound growth
Revenue vs profit
| 3 years | 5 years | |
|---|---|---|
| Revenue CAGR | 3.3% | 15.8% |
| Profit CAGR | -15.6% | 5.0% |
4 · The owners
Who holds it, and are they adding?
Down 0.41 pts over 8 quarters.
Down 3.01 pts over 8 quarters.
Up 7.25 pts over 8 quarters.
+19 versus the previous month.
Shareholding pattern (%)
Quarter by quarter
| Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | Change | |
|---|---|---|---|---|---|---|---|---|---|
| Promoter | 41.69 | 41.61 | 41.55 | 41.49 | 41.45 | 41.45 | 41.28 | 41.28 | -0.41 |
| FII | 12.64 | 12.17 | 12.66 | 12.77 | 12.61 | 12.21 | 11.21 | 9.63 | -3.01 |
| DII | 13.29 | 13.83 | 14.46 | 15.57 | 16.28 | 16.75 | 16.67 | 20.54 | +7.25 |
| Public | 32.38 | 32.39 | 31.34 | 30.17 | 29.66 | 29.6 | 30.85 | 28.55 | -3.83 |
Mutual fund holdings · Oct 2026
74 schemes hold this stock
55 the month before.
- SBI Children's Fund - Investment Plan2.58% of NAV
- SBI Resurgent India Opportunities Scheme2.16% of NAV
- Bank of India ELSS Tax Saver Fund2.04% of NAV
- Sundaram Small Cap Fund1.88% of NAV
- SBI Smallcap Fund1.53% of NAV
- Bank of India Business Cycle Fund1.45% of NAV
- Bank Of India SMALL CAP FUND1.41% of NAV
- Bajaj Finserv Small Cap Fund1.22% of NAV
5 · The model view
What does our factor model say?
Factor scores, model flags and screen results for E.I.D.PAR are part of the Wright portfolio review.
Run your free portfolio reviewWatchouts
What to review
Model flags are shown inside the portfolio review, alongside your other holdings.
Related stocks
Other Food Products stocks
Quick answers
Common questions about E.I.D.PAR
What is the E.I.D.PAR share price?
E.I.D.PAR (EIDPARRY) last closed at ₹642.25, down 0.73% on the day. Its 52-week range is ₹600.45 to ₹1,068.70.
What is the market cap of E.I.D.PAR?
E.I.D.PAR has a market capitalisation of about ₹11,452 crore. Its price-to-earnings ratio is 38.7.
How are E.I.D.PAR's latest results?
E.I.D.PAR reported revenue of ₹11,213 crore for Sep 2026, down 3.5% from a year earlier. Net profit was ₹253 crore (down 40.3% year on year). Return on equity was 6.5% in Mar 2026. Promoter holding was 41.28% in Sep 2026, down 0.41 points over 8 quarters.
Who owns E.I.D.PAR?
As of Sep 2026, shareholding was: Promoter 41.28%, FII 9.63%, DII 20.54%, Public 28.55%.
How many mutual funds hold E.I.D.PAR?
74 mutual fund schemes held E.I.D.PAR in October 2026. That compares with 55 the month before.
Corporate actions
Recent dividends, bonuses and splits
- 21 Nov 2023 · Interim Dividend - Rs. 4
- 21 Apr 2023 · Interim Dividend - Rs. 4
- 22 Nov 2022 · Interim Dividend - Rs. 5.5
- 10 Mar 2022 · Interim Dividend - Rs. 5.5
- 17 Nov 2021 · Interim Dividend - Rs. 5.5
- 04 Apr 2019 · Interim Dividend - Rs. 1
Financials are as reported by the company (consolidated), in ₹ crore. Source: FinEdge exchange filings feed. Figures can differ from other sites because of one-off items and restatements. Callouts above are arithmetic on reported data, not recommendations.
Research data on this page is provided under Wright Research's SEBI Research Analyst registration. The Terms & Conditions of our Research Analyst services apply.